body > *:not(noscript) { display: none !important; } noscript { display: block !important; } .no-js-warning { display: flex !important; min-height: 100vh; align-items: center; justify-content: center; padding: 20px; background: #f8f9fa; text-align: center; } .no-js-card { max-width: 500px; padding: 30px; border-radius: 12px; background: white; box-shadow: 0 10px 30px rgba(0,0,0,0.08); font-family: Arial, sans-serif; } .no-js-card h1 { margin-bottom: 10px; }

JavaScript Required

JavaScript is required for this website to work correctly and provide a smooth user experience. Please enable JavaScript in your browser, then refresh the page.

Top story

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Read full story

Milwaukee Closes More Schools to Address Lead Crisis

Drugs.com - Daily MedNews

Wed, 30 Apr 2025

New HHS Ad Campaign Urges Americans to 'Take Back Your Health'

Drugs.com - Daily MedNews

Wed, 30 Apr 2025

Most Americans Want Easy Early Testing For Alzheimer's

Drugs.com - Daily MedNews

Wed, 30 Apr 2025

App Helps Asthma Patients Track Symptoms

Drugs.com - Daily MedNews

Wed, 30 Apr 2025

H.H.S. Scraps Studies of Vaccines and Treatments for Future Pandemics

The New York Times - Drugs & Pharmaceuticals

By Carl Zimmer and Apoorva Mandavilli - Wed, 26 Mar 2025

F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

The New York Times - Drugs & Pharmaceuticals

By Ellen Barry - Wed, 26 Feb 2025